Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 8/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3596015 | 1.00 | ALDH1A1 (0.60) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3598076 | 0.91 | APP (0.64) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3598073 | 0.91 | APP (0.64) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3597965 | 0.82 | MAPT (0.72) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3597959 | 0.82 | MAPT (0.72) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3594397 | 0.81 | NPSR1 (0.69) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL3594393 | 0.81 | NPSR1 (0.69) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL1321093 | 0.78 | CYP1A1 (0.60) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL17824538 | 0.78 | LMNA (0.77) | ALDH1A1LMNAKDM4EPKMAPP | |
| SCHEMBL17824546 | 0.78 | LMNA (0.77) | ALDH1A1LMNAKDM4EPKMAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795249-B2 | Certain pyrazoline derivatives with kinase inhibitory activity | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-09-14 | — | — | US | disclosed |
| US-20080171754-A1 | Certain pyrazoline derivatives with kinase inhibitory activity | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171754-A1 | Certain pyrazoline derivatives with kinase inhibitory activity | MAP3K5, MAP4K5, MAP3K20 | ALDH1A1 3584/4885LMNA 2987/4885KDM4E 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.